Topical therapy drugs containing silver in acute adenoiditis sinusitis in children

• Main Author: I. M. Kirichenko
• Format: Article
• Language: Russian
• Published: Remedium Group LLC 2020-03-01
• Series: Медицинский совет
• Subjects: acute adenoiditis and sinusitis in children; topical silver preparations; effectiveness
• Online Access: https://www.med-sovet.pro/jour/article/view/5540
• ISSN: 2079-701X; 2658-5790

The article  presents  the  results  of Russian authors’ research  aimed at studying the  clinical efficacy of topical  drugs containing silver in treating  acute  serous adenoiditis  and sinusitis in children. The authors  noted  the efficacy and safety of the drug (silver proteinate and polyvinyl-N-pyrrolidone) in the complex treatment of inflammatory diseases  of the nose and paranasal sinuses in children. Clinical observation  was carried out – comparison  of two groups of 30 patients aged from 5 to 14 years, average  age 6 years 3 months, the groups included: 17 boys (56.7%) and 13 girls (43.3%), all children had adenoid  vegetations of the 1st-2nd degree. To assess the clinical efficacy of the drug, a control group of children with similar pathology was recruited, comparable  in age and sex (14 boys and 16 girls). The main group received the drug Sialor and irrigation therapy. The control group received local antibacterial drugs and decongestants according to age. At the beginning of treatment normal values of mucociliary transport  were not observed  in any patient  (0%) of the main and control groups. Disorder of the 1st degree  mucociliary transport  function was determined in 6 children (20%) of the main group and 7 children (23.3%) of the control group, 2nd degree  – in 21 children (70%) of the main group and 19 children (63.3%) of the control group, 3rd degree – in 3 (10%) patients of the main group and 4 children (13.4%) of the control group. In 7 days from the beginning of treatment normal values of MCT were observed in 28 patients (93.3%) of the main group and 9 patients (30%) of the control group, the disorder of MCT function of the 1st degree  had 3 patients (9%) of the main and control groups, the 2nd degree  was not in the main group and was revealed  in 18 patients (60%) of the control group, no disorder of MCT function of the 3rd degree  was revealed  (neither in the main nor control groups).The average  time of MCT was: before treatment – 49 minutes  (main group) and 47 minutes  (control group), the 3rd day of treatment – 28 minutes (main group) and 36 minutes (control group). On the 7th day of the drug intake – 14 minutes (main group) and 21 minutes  (control group). Thus, normalization  of MCT time was noted only in patients of the main group. On the 7th day of treatment with Sialor in the main group of children under examination,  nasal mucosa edema, nasal excretion  and adenoid  tissue size decreased, mucociliary transport parameters normalized, nasal breathing improved.Sialor has a pronounced  anti-inflammatory and anti-edema effect, is well tolerated by patients and can be recommended for inclusion in standard  treatment protocols of patients with diseases  of the nasal cavity, paranasal sinuses.